Pfizer presses AstraZeneca case (11)

IOL 2014.05.12 15:37
By Reuters Reuters. US drugmaker Pfizer. London - US drugmaker Pfizer pressed the scientific case for its controversial plan to acquire AstraZeneca on Monday as its chief executive prepared for a grilling from British lawmakers. In the latest phase of Pfizer's campaign to counter critics of its proposed $106 billion deal, research head Mikael Dolsten said he had been through five different mergers and acquisitions and denied such big transactions
PASCAL, PFIZER, MERGER, CURIOSITY, TAKEOVER, SCIENTIST, Read, Cameron, Willetts, USA, United Kingdom